1.
Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study
by Griffiths, Paul D, Prof
The Lancet (British edition), 2016, Vol.389 (10068), p.538-546
2.
Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation
by Griffiths, Paul D, Prof
The Lancet infectious diseases, 2012, Vol.12 (10), p.790-798
3.
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
by Griffiths, Paul D, Prof
The Lancet (British edition), 2011, Vol.377 (9773), p.1256-1263
4.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
by Griffiths, Christopher E M, Prof
The Lancet (British edition), 2015, Vol.386 (9993), p.541-551
5.
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy
by Deayton, Jane R
The Lancet (British edition), 2004-06-26, Vol.363 (9427), p.2116-2121
6.
Coeliac disease and neurological dysfunction: a case-control study
by Currie, Stuart, Dr
The Lancet (British edition), 2014, Vol.383, p.S39-S39
7.
A whole-economy model of the health co-benefits of strategies to reduce greenhouse gas emissions in the UK
by Keogh-Brown, Marcus, Dr
The Lancet (British edition), 2012, Vol.380, p.S52-S52
